» Articles » PMID: 31554919

Plasma Metabolites Associated with Homeostatic Model Assessment of Insulin Resistance: Metabolite-model Design and External Validation

Overview
Journal Sci Rep
Specialty Science
Date 2019 Sep 27
PMID 31554919
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Different plasma metabolites have been related to insulin resistance (IR). However, there is a lack of metabolite models predicting IR with external validation. The aim of this study is to identify a multi-metabolite model associated to the homeostatic model assessment (HOMA)-IR values. We performed a cross-sectional metabolomics analysis of samples collected from overweight and obese subjects from two independent studies. The training step was performed in 236 subjects from the SATIN study and validated in 102 subjects from the GLYNDIET study. Plasma metabolomics profile was analyzed using three different approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (NMR). Associations between metabolites and HOMA-IR were assessed using elastic net regression analysis with a leave-one-out cross validation (CV) and 100 CV runs. HOMA-IR was analyzed both as linear and categorical (median or lower versus higher than the median). Receiver operating characteristic curves were constructed based on metabolites' weighted models. A set of 30 metabolites discriminating extremes of HOMA-IR were consistently selected. These metabolites comprised some amino acids, lipid species and different organic acids. The area under the curve (AUC) for the discrimination between HOMA-IR extreme categories was 0.82 (95% CI: 0.74-0.90), based on the multi-metabolite model weighted with the regression coefficients of metabolites in the validation dataset. We identified a set of metabolites discriminating between extremes of HOMA-IR and able to predict HOMA-IR with high accuracy.

Citing Articles

Serum metabolomic signatures of plant-based diets and incident chronic kidney disease.

Kim H, Yu B, Li X, Wong K, Boerwinkle E, Seidelmann S Am J Clin Nutr. 2022; 116(1):151-164.

PMID: 35218183 PMC: 9257476. DOI: 10.1093/ajcn/nqac054.


Circulating Metabolites Associated with Body Fat and Lean Mass in Adults with Overweight/Obesity.

Papandreou C, Garcia-Gavilan J, Camacho-Barcia L, Hansen T, Sjodin A, Harrold J Metabolites. 2021; 11(5).

PMID: 34068443 PMC: 8153621. DOI: 10.3390/metabo11050317.


CANTARE: finding and visualizing network-based multi-omic predictive models.

Siebert J, Saint-Cyr M, Borengasser S, Wagner B, Lozupone C, Gorg C BMC Bioinformatics. 2021; 22(1):80.

PMID: 33607938 PMC: 7896366. DOI: 10.1186/s12859-021-04016-8.


Body Composition and the Components of Metabolic Syndrome in Type 2 Diabetes: The Roles of Disease Duration and Glycemic Control.

Abulmeaty M, Aljuraiban G, Alaidarous T, Alkahtani N Diabetes Metab Syndr Obes. 2020; 13:1051-1059.

PMID: 32308455 PMC: 7147622. DOI: 10.2147/DMSO.S248842.

References
1.
Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama J . Lactate, a Neglected Factor for Diabetes and Cancer Interaction. Mediators Inflamm. 2017; 2016:6456018. PMC: 5203906. DOI: 10.1155/2016/6456018. View

2.
Simopoulos A . Is insulin resistance influenced by dietary linoleic acid and trans fatty acids?. Free Radic Biol Med. 1994; 17(4):367-72. DOI: 10.1016/0891-5849(94)90023-x. View

3.
Boden G . Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011; 18(2):139-43. PMC: 3169796. DOI: 10.1097/MED.0b013e3283444b09. View

4.
Gannon N, Schnuck J, Vaughan R . BCAA Metabolism and Insulin Sensitivity - Dysregulated by Metabolic Status?. Mol Nutr Food Res. 2018; 62(6):e1700756. DOI: 10.1002/mnfr.201700756. View

5.
Manning P, Sutherland W, Walker R, Williams S, de Jong S, Ryalls A . Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care. 2004; 27(9):2166-71. DOI: 10.2337/diacare.27.9.2166. View